Gå frakoblet med Player FM -appen!
Douglas Holtz-Eakin, “Indications are going to be deeply affected by the IRA”
Manage episode 415788851 series 2401268
Douglas Holtz-Eakin was formerly a professor of economics at Syracuse University and served as the director of the Congressional Budget Office from 2003 – 2005. He was the chief economic policy adviser to Senator John McCain's 2008 presidential campaign and is currently president of the American Action Forum, a highly respected think tank in Washington, DC.
While heading the CBO, Douglas played a pivotal role in designing and implementing the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, aka the Medicare Part D prescription drug benefit. Given his experience, in this podcast, we reflect upon how that legislation led to the rapid expansion of the U.S. innovative biopharma sector and the material risks posed by the Inflation Reduction Act.
See omnystudio.com/listener for privacy information.
101 episoder
Manage episode 415788851 series 2401268
Douglas Holtz-Eakin was formerly a professor of economics at Syracuse University and served as the director of the Congressional Budget Office from 2003 – 2005. He was the chief economic policy adviser to Senator John McCain's 2008 presidential campaign and is currently president of the American Action Forum, a highly respected think tank in Washington, DC.
While heading the CBO, Douglas played a pivotal role in designing and implementing the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, aka the Medicare Part D prescription drug benefit. Given his experience, in this podcast, we reflect upon how that legislation led to the rapid expansion of the U.S. innovative biopharma sector and the material risks posed by the Inflation Reduction Act.
See omnystudio.com/listener for privacy information.
101 episoder
Alle episoder
×1 Breaking Barriers: The Prime Rose Project and Off-Label Drug Innovations 29:15
1 Impact of the Inflation Reduction Act on Venture Capital in Life Sciences 36:11
1 Investing in Health: Pathways to a Well-being Economy and Smarter Healthcare Budgets 35:30
1 Addressing Europe's Health Challenges: Innovation, Prevention, and Policy 38:30
1 The Future of Biotech: Steve Potts on Innovation, Policy, and the Impact of the IRA 24:58
1 Revolutionizing Healthcare with Real-World Data 27:13
1 Exploring the Intersection of Intellectual Property and Biotech Innovation 56:52
1 Unlocking the Power of Genomic Data: NashBIO's Role in Healthcare Innovation 19:00
1 MEP Pernille Weiss – Rapporteur of the EU GPL 47:33
1 Transforming Health Communications: Insights from Virginia Amann 26:51
1 Joe Panetta – Policy Impacts on California Biopharma 27:30
1 Niklas Blomberg, Executive Director, EU Innovative Health Initiative 19:58
1 Congressman Michael Burgess – IRA and March-in Rights 28:55
1 Kim Hawkins - Project Co-Lead of IMI’s Trials@Home 32:51
1 Douglas Holtz-Eakin, “Indications are going to be deeply affected by the IRA” 54:59
Velkommen til Player FM!
Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.